Dexibuprofen for fever in children with upper respiratory tract infection

Autor:	Chang Keun Kim, Jinho Yu, Kye Shik Shim, Zak Callaway, Eun Mi Kwon, Young Yull Koh, Ji Tae Choung
Rok vydání:	2013
Předmět:	business.industry Significant difference medicine.disease Ibuprofen Tertiary care Confidence interval Dexibuprofen law.invention Upper respiratory tract infection Randomized controlled trial law Anesthesia Pediatrics Perinatology and Child Health medicine Adverse effect business medicine.drug
Zdroj:	Pediatrics International. 55:443-449
ISSN:	1328-8067
Popis:	Background The aim of this study was to investigate the safety and efficacy of dexibuprofen compared to ibuprofen. Methods This double-blind, double-dummy study enrolled patients from January 2008 to May 2009 presenting at one of five tertiary care centers in Seoul, Korea with febrile illness who were then given one of three active treatments: one dose of dexibuprofen 2.5 or 5 mg/kg (DEX 1); dexibuprofen 3.5 or 7 mg/kg (DEX 2); or ibuprofen 5 or 10 mg/kg (control) syrup. Those with a temperature
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9d8bda5233648ae05d0e338c1b2975a5 https://doi.org/10.1111/ped.12125 Zobrazit plný text záznamu Plný text